Skip to content

An OCD Prevention Programme for at Risk Adults

The Efficacy of an OCD Prevention Programme for at Risk Adults: a Randomized Clinical Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06262464
Acronym
ØCD
Enrollment
200
Registered
2024-02-16
Start date
2024-02-09
Completion date
2025-12-31
Last updated
2025-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive-Compulsive Disorder

Keywords

Risk, Prevention

Brief summary

The main purpose of this randomised clinical trial is to test the efficacy of a prevention program for adult who are at risk of developing OCD, thus constituting a form of tertiary prevention.

Detailed description

After being informed about the study and giving written informed consent, all eligible participants will be randomised into the experimental group or the control group (TAU). Participants will be blind to the group allocation. The experimental group will undergo a two weeks OCD prevention program, consisting of three group sessions per week. The control group will not receive any intervention. Researchers will compare the experimental group to the control group to test wether the prevention programme is efficient in reducing OCD symptomatology.

Interventions

BEHAVIORALPrevention

A cognitive-behavioural prevention programme.

Sponsors

Romanian National Authority for Scientific Research
CollaboratorUNKNOWN
Babes-Bolyai University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

\- age over 18

Exclusion criteria

* clinically diagnosed OCD * current psychiatric/psychotherapeutic treatment * personality disorder diagnosis * suicidal ideation

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in depressive symptoms on the PHQ-9 after the interventionBaseline and Week 2The PHQ-9 is a validated self-report instrument assessing depressive symptoms. Possible scores range from 0 to 27. Change = end of intervention score - baseline score
Change from baseline in OCD symptoms on the OCI-R after the interventionBaseline and Week 2The OCI-R is a validated self-report instrument assessing OCD symptoms. Possible scores range from 0 to 72. Change = end of intervention score - baseline score
Change from baseline in anxiety symptoms on the GAD-7 after the interventionBaseline and Week 2The GAD-7 is a validated self-report instrument assessing anxiety symptoms. Possible scores range from 0 to 21. Change = end of intervention score - baseline score

Secondary

MeasureTime frameDescription
Change from baseline in resilience on the RSA after the interventionBaseline and Week 2The RSA is a validated self-report instrument assessing resilience in adults. Possible scores range from 43 to 215. Change = end of intervention score - baseline score
Change from baseline in uncertainty intolerance on the IUS after the interventionBaseline and Week 2The IUS is a validated self-report instrument assessing intolerance of uncertainty. Possible scores range from 27 to 135. Change = end of intervention score - baseline score
Change from baseline in experiential avoidance on the EAQ after the interventionBaseline and Week 2The EAQ is a validated self-report instrument assessing experiential avoidance. Possible scores range from 15 to 90. Change = end of intervention score - baseline score
Change from baseline in cognitive distortions on the OBQ-44 after the interventionBaseline and Week 2The OBQ-44 is a validated self-report instrument assessing cognitive distortions in OCD. Possible scores range from 7 to 308. Change = end of intervention score - baseline score

Other

MeasureTime frameDescription
Change from baseline in life quality on the WHOQOL-BREF after the interventionBaseline and Week 2The WHOQOL-BREF is a validated self-report instrument assessing life quality in adults. Change = end of intervention score - baseline score
Change from baseline in global health on the GHQ-12 after the interventionBaseline and Week 2The GHQ-12 is a validated self-report instrument assessing global health in adults. Possible scores range from 0 to 36. Change = end of intervention score - baseline score
Change from baseline in irrationality on the ATQ after the interventionBaseline and Week 2The ABS-AV is a validated self-report instrument assessing irrationality in adults. Possible scores range from 24 to 120 Change = end of intervention score - baseline score

Countries

Romania

Contacts

Primary ContactRoxana Cardoș, PhD
roxanaoltean@psychology.ro0040751477323

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026